Glaxosmithkline Q3 Consol Loss EGP 34.8 Million

About this update from Glaxosmithkline S.a.e.

GLAXOSMITHKLINE SAE EGX:BIOC:GLAXOSMITHKLINE Q3 CONSOL NET LOSS ATTRIBUTABLE EGP 34.8 MILLIONGLAXOSMITHKLINE Q3 CONSOL NET SALES EGP 1.01 BILLION

View stock analysis, news, and events for Glaxosmithkline S.a.e.